Since HLJDT and its components modulated intracellular levels of APP and CTFs in N2a-SwedAPP, we investigated the effect of HLJDT and its components on the level of intracellular Aβ, which is a key factor in AD progression [29]. This evidence concerns the gene APP and Alzheimer disease.